Assert-IQ vs CT VScore+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

CT VScore+

by CT VScore+

AI Verdict

Tool A (Assert-IQ) is designed for long-term, continuous monitoring of heart rhythms to detect and manage arrhythmias, utilizing an insertable cardiac monitor. In contrast, Tool B (CT VScore+) is an AI-powered software that automates cardiac calcium scoring from CT images for coronary risk assessment. While both are AI tools in cardiology, they address distinct diagnostic areas: heart rhythm disorders versus structural coronary artery disease.

Choose Assert-IQ if…

Choose Assert-IQ if you require long-term, continuous monitoring for patients with suspected or intermittent heart rhythm disorders that may not be captured by shorter-term diagnostic methods. This tool is ideal for comprehensive arrhythmia detection over several years, enabling proactive management and remote oversight of cardiac activity.

View Assert-IQ →

Choose CT VScore+ if…

Choose CT VScore+ if your primary goal is to efficiently and accurately assess a patient's coronary artery disease risk through automated cardiac calcium scoring. This AI-powered solution is best suited for integrating with existing CT imaging workflows to provide rapid Agatston and volume scores for cardiovascular risk stratification.

View CT VScore+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	CT VScore+
Deployment	Subcutaneously implanted device with mobile app connectivity	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CT VScore+

CT VScore+ directly enhances clinician usability by automating cardiac calcium scoring and removing manual data entry, streamlining a previously time-consuming process. While Assert-IQ offers patient convenience and remote monitoring, CT VScore+'s impact on direct clinical workflow efficiency is more explicitly stated and tangible.

Clinical Value

Assert-IQ

Assert-IQ provides long-term continuous cardiac monitoring for up to six years, offering advanced arrhythmia detection and proactive clinician alerts, which is critical for diagnosing and managing elusive heart rhythm disorders. This sustained, in-depth monitoring capability offers a profound and ongoing clinical impact on patient management.

Pricing & Value

Tie

Both tools require direct contact for institutional or enterprise pricing, and neither offers a free trial. Without specific pricing details or publicly available cost-benefit analyses, it is impossible to determine which offers superior value for money.

Enterprise Readiness

Assert-IQ

Assert-IQ offers a hybrid deployment model, providing greater flexibility for large health systems compared to CT VScore+'s on-premise-only deployment. Assert-IQ also explicitly targets large health systems and offers data export capabilities, which are crucial for integration and analytics in complex enterprise environments.

Innovation

Assert-IQ

Assert-IQ demonstrates significant innovation in device technology with its long-term continuous cardiac monitoring (up to 6 years), advanced arrhythmia detection algorithms, and Bluetooth Low Energy data transmission. While CT VScore+ innovates in workflow automation, Assert-IQ represents a more fundamental advancement in medical device capability and physiological data acquisition.

Support & Docs

Tie

The provided structured facts do not contain specific information regarding the support and documentation for either tool. Both Abbott Medical and Canon Medical Informatics are established companies expected to provide comprehensive support for their products, making it impossible to differentiate them on this dimension without further specific details.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	CT VScore+
Name	Assert-IQ	CT VScore+
Primary Function	Long-term, continuous monitoring and advanced arrhythmia detection for suspected heart rhythm disorders.	Automates cardiac calcium scoring from ECG-gated, non-contrast cardiac CT images for coronary risk assessment.
Company	Abbott Medical	Canon Medical Informatics
Target Specialties	Cardiology, Internal Medicine	Cardiology, Radiology
Key Feature: Core Clinical Function	Long-term continuous cardiac monitoring (up to 6 years) with advanced arrhythmia detection algorithms.	Automated cardiac calcium scoring, providing Agatston and volume scores.
Key Feature: Operational Benefit	Remote monitoring capabilities with proactive clinician alerts and patient activator for symptom logging.	Removes manual data entry from reporting and highlights segmented calcium on CT images.

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and CT VScore+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of Assert-IQ compared to CT VScore+?

Assert-IQ is designed for long-term, continuous monitoring and advanced arrhythmia detection to help diagnose and manage patients with suspected heart rhythm disorders. In contrast, CT VScore+ is an AI-powered software application that automates cardiac calcium scoring from CT images for coronary risk assessment.

How do the technologies and patient procedures differ between Assert-IQ and CT VScore+?

Assert-IQ utilizes a minimally invasive insertable cardiac monitor (ICM) that continuously tracks heart rhythms for up to six years. CT VScore+ is a non-invasive software application that analyzes ECG-gated, non-contrast cardiac CT images to automatically generate calcium scores.

What specific data and insights do these tools provide to clinicians?

Assert-IQ provides long-term continuous cardiac monitoring data, advanced arrhythmia detection algorithms, remote monitoring capabilities, and proactive clinician alerts, along with patient-logged symptoms. CT VScore+ automates the generation of Agatston and volume calcium scores, highlights segmented calcium on CT images, and offers calcium percentile comparisons to reference data for coronary risk assessment.

Which medical specialties are the primary users of Assert-IQ versus CT VScore+?

Assert-IQ is primarily targeted towards Cardiology and Internal Medicine specialties. CT VScore+ is designed for use in Cardiology and Radiology specialties.

What is the monitoring or assessment duration offered by each tool?

Assert-IQ provides long-term continuous cardiac monitoring for up to six years. CT VScore+ offers a single-point, automated assessment of coronary artery calcification from a cardiac CT image.